[1]
O. . Yersal, “Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?”, Med Sci Discov, vol. 5, no. 10, pp. 344–349, Oct. 2018.